DealFlow Dispatch – bioAffinity Q2 Trigger
bioAffinity’s CyPath® Lung test volume jumps 62% Y/Y. Time to lock in logistics and reimbursement deals. Add this trigger to your pipeline now.
Published on
Do not index
Do not index
🚀 Battle Card: bioAffinity Technologies, Inc.
Quick trigger:
👤 Decision Maker in the News
- Dr. Gordon Downie, Chief Medical Officer · 🔗 LinkedIn
💡 Why It Matters
- This bioAffinity Technologies sales trigger shows CyPath® Lung testing adoption climbing 62% Y/Y, signaling a need for scalable sample logistics and reimbursement support. Leverage this bioAffinity Technologies sales trigger to time your outreach. → Source
🎯 Core Pain Point
- Scaling national sample logistics amid record monthly volumes
- Aligning test pricing with private payer reimbursements
💰 What to Pitch
- Primary: Logistics management platform → Reduce delivery costs & ensure on-time testing
- Expansion: Reimbursement analytics service → Maximize per-test profitability
🗺️ Quick Context
- HQ: San Antonio, TX
- Employees: 52
- Rev: ≈ $5 M
- Website: http://www.bioaffinitytech.com
🤼 Competitive Intel
Which other vendors you’ll probably face to win bioAffinity Technologies, Inc.’s business.
- Cardinal Health OptiFreight® Logistics — Sample transport solutions
- Unique edge: Integrated tracking & nationwide coverage
- Evaluated by VP Ops for delivery reliability
- Thermo Fisher Scientific — Lab supply & logistics
- Unique edge: End-to-end cold chain management
- Evaluated by Dir. of Product for supply efficiency
- Guardant Health — Liquid biopsy diagnostics
- Unique edge: Established oncology test portfolio
- Evaluated by CMO for diagnostic accuracy
- Labcorp — Clinical lab services
- Unique edge: High-throughput testing capacity
- Evaluated by COO for volume scalability
- Foundation Medicine — Cancer genomics
- Unique edge: Comprehensive genomic profiling
- Evaluated by Head of Marketing for strategic partnerships
✅ Do-Now Checklist
Connect with all decision makers on LinkedIn (links above)
Draft first-touch email + DM using the Copy-My-Prompt block (Step 7)
Schedule follow-ups in CRM (Day 3 & Day 10)
Use the bioAffinity Technologies sales trigger data in your messaging
Next Step
Capitalize on this bioAffinity Technologies sales trigger daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑a logistics management platform❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑punchy❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Dr. Gordon
COMPANY = bioAffinity Technologies, Inc.
DEPT = Ops & Supply Chain
SIZE = ≈ 52
BOTTLENECK = scaling national sample logistics
EVENT = Reports Second Quarter 2025 Results
DETAIL = CyPath® Lung revenues up 62%
PAIN = scaling national sample logistics
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250814042365&div=41152219
SIM_CO = Cardinal Health OptiFreight® Logistics
WIN_METRIC = 62% increase in testing revenue
NEXT_SIZE = ≈ 100
EMP_EST = 52
REV_EST = ≈ $5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ 52-person Ops & Supply Chain
Dr. Gordon—noticed your Ops & Supply Chain team is ≈ 52.
That’s when scaling national sample logistics slows growth.
We helped Cardinal Health OptiFreight® Logistics fix this with a logistics management platform.
Result: 62% increase in testing revenue.
Quick call?
PS—next bottleneck hits ≈ 100.
DM ≤45 words, TONE:
Saw your post about CyPath® Lung revenues up 62% — scaling national sample logistics.
a logistics management platform. ≈ TBD.
Quick chat?